7/31/2021 Amazon com Inc Shares: 1,457,055 $14.72M 3.9% N/A 8.720% Stake.
MarketBeat!
NAUTILUS BIOTECHNOLOGY (NASDAQ:NAUT) PRICE TARGET AND CONSENSUS RATING
2 Wall Street analysts have issued ratings and price targets for Nautilus Biotechnology in the last 12 months. Their average twelve-month price target is $11.50, predicting that the stock has a possible upside of 34.66%. The high price target for NAUT is $13.00 and the low price target for NAUT is $10.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
8/4/2021 The Goldman Sachs Group Initiated Coverage Neutral $10.00
7/13/2021 Jefferies Financial Group Initiated Coverage Buy $13.00
MarketBeat!
Recent NAUT News
- Nautilus Biotechnology Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/07/2024 05:15:12 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2024 09:39:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:46:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:42:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:34:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:30:01 PM
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:26:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/28/2024 12:25:19 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/28/2024 12:15:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 12:04:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:03:30 PM
- Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:17:26 PM
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award • GlobeNewswire Inc. • 11/30/2023 01:00:00 PM
- Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development • GlobeNewswire Inc. • 11/01/2023 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/31/2023 08:02:46 PM
- Nautilus Biotechnology Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/31/2023 12:05:00 PM
- Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 • GlobeNewswire Inc. • 10/11/2023 12:05:00 PM
- Nautilus Biotechnology to Participate in Upcoming September Investor Conferences • GlobeNewswire Inc. • 09/06/2023 11:30:00 AM
- Nautilus Biotechnology to Participate in Upcoming August Investor Conferences • GlobeNewswire Inc. • 08/04/2023 12:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM